Bibliography
- Tsokos GC. Systemic lupus erythematosus. N Engl J Med 2011;365(22):2110-21
- Trials C. Study of Epratuzumab versus placebo in subjects with moderate to severe general systemic lupus erythematosus (EMBODY 1). 2014. Available from: http://www.clinicaltrials.gov/ct2/show/NCT01262365?term=embody&rank=1
- Strand V, Petri M, Kalunian K, et al. Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006. Rheumatology (Oxford) 2014;53(3):502-11
- Wallace DJ, Gordon C, Strand V, et al. Efficacy and safety of epratuzumab in patients with moderate/severe flaring systemic lupus erythematosus: results from two randomized, double-blind, placebo-controlled, multicentre studies (ALLEVIATE) and follow-up. Rheumatology (Oxford) 2013;52(7):1313-22